CDK9, a cyclin dependent kinase, is an essential regulator of cancer-promoting transcriptional programs and an important driver in MYC-driven solid tumors and hematological malignancies.
About
A seasoned team experienced in developing cancer medicines to create a fully integrated oncology company.